Guidance on allergens in Traditional Chinese Medicine (TCM)

Market Alerts

November 2021

  • SCNM Dedicates Ric Scalzo Institute of Botanical Research
  • August 2021

    July 2021

    March 2021

    February 2021

    November 2020

    October 2020

    September 2020

    August 2020

    July 2020

    June 2020

    April 2020

    February 2020

    January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities
  • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    Guidance on allergens in Traditional Chinese Medicine (TCM)

    Free guidance for AHPA members

    Published: Monday, July 12, 2021

    AHPA has published a revised version of the guidance document titled “Compliance with the Food Allergen Labeling and Consumer Protection Act (FALCPA) for Marketers of Chinese Herbal Products” to include the requirements of the recently adopted Food Allergy Safety, Treatment, Education, and Research Act of 2021 (FASTER Act), which adds sesame to the list of major food allergens that require labeling in the United States. The new requirements in the FASTER Act amend the definition of “major food allergen” in FALCPA and take effect on January 1, 2023.

    AHPA first published this guidance in November 2019, to provide members with a summary of FALCPA and to identify ingredients and preparations found in traditional Chinese herbal ingredients and formulas that may require labeling as major food allergens.

    FALCPA established specific labeling requirements for foods, including dietary supplements, that contain food ingredients identified under this law to be “major food allergens.” The primary labeling requirements for food ingredients covered by FALCPA is simply that these be disclosed on the label of a food product that contains any major food allergen. While this may seem straightforward, failure to properly identify allergens on food labels has become one of the most common reasons for food recalls over the past several years.

    A number of AHPA’s members market products that consist of or contain ingredients used in Chinese herbal traditions such as Traditional Chinese Medicine (TCM), and some of these ingredients require labeling as allergens. Members therefore should understand the requirements of this law when using these ingredients.

    This guidance document addresses the following topics:

    • Major food allergens
    • Tree nuts requiring allergen labels
    • Exemptions to FALCPA labelling
    • Traditional Chinese ingredients and formulas that may contain allergens
    • FDA resources for allergen labeling

    Information collected by AHPA from experts with extensive experience in the composition and processing of ingredients and formulas used in Chinese herbal traditions was used to identify ingredients and formulas that are composed of a major food allergen or that may contain major food allergens due to the method of preparation or processing of an ingredient.

    AHPA acknowledges the contributions of many members of the AHPA Chinese Herbal Products Committee in developing and maintaining this guidance and welcomes additional suggestions so the guidance can be revised as additional insights are gained through its practical use.

    Download the Guidance here.

    Print

    2021 Annual Fund Sponsors

        

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.